These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5319619)

  • 61. [Inhalations of extracts from Gingko biloba in vasomotor rhinitis and in the bronchitic syndrome].
    Volkner JH
    Dtsch Med J; 1967 Sep; 18(17):527-33. PubMed ID: 5590539
    [No Abstract]   [Full Text] [Related]  

  • 62. Background of mucolytic treatments in chronic bronchitis.
    Minette A
    Eur J Respir Dis; 1983 Aug; 64(6):401-4. PubMed ID: 6884453
    [No Abstract]   [Full Text] [Related]  

  • 63. [Inhalation therapy in chronic mucus retention].
    Köhler D
    Pneumologie; 1990 Oct; 44(10):1166-70. PubMed ID: 2281059
    [No Abstract]   [Full Text] [Related]  

  • 64. Do mucolytics help in chronic bronchitis and asthma?
    Drug Ther Bull; 1984 Apr; 22(8):29-31. PubMed ID: 6714085
    [No Abstract]   [Full Text] [Related]  

  • 65. [Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
    Rossini G
    Med Monatsschr; 1970 Jun; 24(6):270-2. PubMed ID: 5525114
    [No Abstract]   [Full Text] [Related]  

  • 66. [Antitussives, mucolytics, antibiotics--what do you prescribe for bronchitis?].
    Füessl HS
    MMW Fortschr Med; 2008 Jan; 150(3-4):26. PubMed ID: 18326474
    [No Abstract]   [Full Text] [Related]  

  • 67. [The relationship between bacteriological and clinical results in patients with chronic bronchitis during long-term therapy with tetracycline and sulfaphenazole].
    Djajadiningrat RJ; Goslings WR; Bergstein PG; Holle P
    Ned Tijdschr Geneeskd; 1966 Feb; 110(9):427-32. PubMed ID: 5324824
    [No Abstract]   [Full Text] [Related]  

  • 68. [Prevention of recurrent attacks of chronic bronchitis by long term treatment with Bisolvomycin].
    Hanke F
    Hippokrates; 1967 Oct; 38(19):779-81. PubMed ID: 5600281
    [No Abstract]   [Full Text] [Related]  

  • 69. Changing strategies for treatment of chronic bronchitis.
    Griffith DE; Perkins RC
    Semin Respir Infect; 1994 Mar; 9(1):49-57. PubMed ID: 7973167
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of mucolytic and expectorant drugs on tracheobronchial clearance in chronic bronchitis.
    Clarke SW; Thomson ML; Pavia D
    Eur J Respir Dis Suppl; 1980; 110():179-91. PubMed ID: 6938381
    [No Abstract]   [Full Text] [Related]  

  • 71. [Chronic bronchitis and modification of its clinical symptoms by Eftapan. Experience values from a therapy study of 14,850 patients].
    Ziegler WJ; Behrendt R; Dylla S; Grossberger D; Müller C; Wichard F
    Med Welt; 1983 Jan; 34(1):23-7. PubMed ID: 6338340
    [No Abstract]   [Full Text] [Related]  

  • 72. [Contribution to the therapy of chronic bronchitis. Experiences with the expectorant and broncholytic agent Spirbon].
    Bauer K
    Wien Med Wochenschr; 1968 Nov; 118(47):1008-10. PubMed ID: 5704261
    [No Abstract]   [Full Text] [Related]  

  • 73. [Multicenter, double-blind study of oral acetylcysteine vs. placebo].
    Brocard H; Charpin J; Germouty J
    Eur J Respir Dis Suppl; 1980; 111():65-9. PubMed ID: 7011834
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Recommendations of the committee for lung diseases and tuberculosis on the therapy of chronic bronchitis].
    Dtsch Gesundheitsw; 1969 Dec; 24(52):2491-6. PubMed ID: 5375933
    [No Abstract]   [Full Text] [Related]  

  • 75. Evaluating the efficacy of mucoactive aerosol therapy.
    Fuloria M; Rubin BK
    Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Treatment of patients with chronic obstructive bronchitis].
    Makeev IuP; Tokmachev IuK; Muromtsev AV; Grib II; Berezko AP; Makeeva EV; Pranovich AG
    Probl Tuberk; 1995; (1):27-9. PubMed ID: 7761375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Experiences with the immunotherapy of chronic asthmatic bronchitis].
    Bürgi H; Regli J
    Schweiz Med Wochenschr; 1967 Aug; 97(31):1007-8. PubMed ID: 5593638
    [No Abstract]   [Full Text] [Related]  

  • 78. Evaluation of efficacy and safety of erdosteine in patients affected by chronic bronchitis during an infective exacerbation phase and receiving amoxycillin as basic treatment (ECOBES, European Chronic Obstructive Bronchitis Erdosteine Study).
    Marchioni CF; Polu JM; Taytard A; Hanard T; Noseda G; Mancini C
    Int J Clin Pharmacol Ther; 1995 Nov; 33(11):612-8. PubMed ID: 8688986
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Clinical experimental studies on the pharmacodynamic effect of alupent in a double blind test with simultaneous bisolvon therapy].
    Seith U
    Med Welt; 1966 Sep; 37():1982-4. PubMed ID: 5341649
    [No Abstract]   [Full Text] [Related]  

  • 80. Acetylcysteine in chronic bronchitis.
    Chodosh S
    Eur J Respir Dis Suppl; 1980; 111():90-2. PubMed ID: 6938413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.